Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
More Videos
Go Fund Yourself: The Tech Pioneers Powering America's Critical-Minerals and Climate-Smart Future
Patriot Critical Minerals powers up America’s critical-minerals future, while Opti-Harvest shows how climate-smart tech helps farmers.
The Compliance Revolution: Closing the Risk Blind Spots with a 360-Degree Strategy
Goutam Nadella, Chief Product Officer at Smarsh, discusses the 360-degree view of risk in the context of compliance.
Why Consumers Are Hitting “Cancel”: Inside the Subscription Fatigue Era
Bank of America economist David Tinsley explains why streaming costs have consumers hitting cancel faster than play.
What September’s Inflation Numbers Really Mean: Insights From S&P Global
Chris Williamson, Chief Business Economist at S&P Global, breaks down September’s CPI print and inflation trends, explaining what it means for markets.
Beyond Binge-Watching: Curiosity Stream’s Vision for Intelligent Entertainment
Curiosity Stream CEO Clint Stinchcomb discusses how educational streaming and innovation are driving strong growth and audience engagement.
Using A.I. to Manage Risk on Wall Street
Patrick Palomo, Principal Solutions Architect at Smarsh, talks about working with Wall Street to deploy A.I. that helps predict and manage risk.
